Tumor suppression by Ink4a-Arf: progress and puzzles

Scott W Lowe1, Charles J Sherr

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA. lowe@cshl.org

Insights

The Ink4a-Arf locus produces tumor suppressors p16(Ink4a) and p19(Arf) (p14(ARF) in humans) that are crucial in cancer. Mouse models reveal distinct roles for these proteins in tumor development and drug response.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The Ink4a-Arf locus encodes two key tumor suppressors: p16(Ink4a) and p19(Arf) (p14(ARF) in humans).
  • These proteins regulate critical cell cycle regulators, including the retinoblastoma protein and p53.
  • Their signaling network is frequently dysregulated in various cancer types.

Purpose of the Study:

  • To elucidate the distinct roles of p16(Ink4a) and p19(Arf) in tumor suppression.
  • To investigate the differential responsiveness of these tumor suppressors to therapeutic agents.

Main Methods:

  • Utilized mouse tumor models to study Ink4a-Arf locus products.
  • Differentiated the functional activities of p16(Ink4a) and p19(Arf) in tumor onset.
  • Assessed drug sensitivity associated with p16(Ink4a) and p19(Arf) activities.

Main Results:

  • Mouse models demonstrated that p16(Ink4a) and p19(Arf) have separate functions in regulating tumor initiation.
  • Differences in drug responsiveness were observed between p16(Ink4a) and p19(Arf) pathways.
  • The Ink4a-Arf locus responds to cellular stress, impacting proliferation and apoptosis.

Conclusions:

  • p16(Ink4a) and p19(Arf) possess distinct tumor suppressor activities.
  • Targeting these pathways may offer differential therapeutic strategies in cancer treatment.
  • Understanding the Ink4a-Arf network is vital for cancer therapy development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...